Individualized medical decision making: Necessary, achievable, but not yet attainable

Archives of Internal Medicine

Volumn 170, Issue 6, 2010, Pages 566-569

  Fraenkel, Liana ^a   Fried, Terri R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; COMORBIDITY; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

EID: 77951075444     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.8     Document Type: Article

References (33)

1. Kattan MW, Vickers A. Incorporating predictions of individual patient risk in clinical trials. Urol Oncol. 2004;22(4):348-352. (Pubitemid 38993315)
2. Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients. JAMA. 2007;298(10):1209-1212.
3. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870-2874.
4. Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008;149(1):11-19.
5. Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med. 2006;145(9):646-653. (Pubitemid 46768839)
6. Wyatt JC, Altman DG. Commentary: prognostic models: clinically useful or quickly forgotten? BMJ. 1995;311:1539-1541.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867.
8. Fuster V, Ryden LE, Asinger RW, et al; American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 2001;38(4):1231-1266.
9. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713-719. (Pubitemid 43290267)
10. Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130(5):1390-1396. (Pubitemid 44786731)
11. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105(2):91-99. (Pubitemid 28405230)
12. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414-1419. (Pubitemid 47052441)
13. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290(8):1049-1056.
14. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the "DEALE"), II: use in medical decision-making. Am J Med. 1982;73(6):889-897. (Pubitemid 13211835)
15. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-2870. (Pubitemid 32537350)
16. Hernández-Díaz S, García Rodríguez LA. Cardio-protective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 2006;4:22.
17. Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med. 2007;120(8):700-705. (Pubitemid 47176507)
18. Vandenbroucke JP, Psaty BM. Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects. JAMA. 2008;300(20):2417-2419.
19. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med. 2000;15(10):723-730.
20. Hernández-Díaz S, Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160(14):2093-2099.
21. Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56(10):1839-1844.
22. Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061-1066. (Pubitemid 34984621)
23. Rosenfeld KE, Wenger NS, Kagawa-Singer M. End-of-life decision making: a qualitative study of elderly individuals. J Gen Intern Med. 2000;15(9):620-625.
24. Gorelick PB. Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation? Stroke. 2007;38(5):1652-1654.
25. Lip GYH, Karpha M. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest. 2006;130(6):1823-1827. (Pubitemid 46033440)
26. Watson T, Lip GY. Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited. Stroke. 2007;38(10):e107-e108. http://stroke .ahajournals.org/cgi/content/full/38/10/e107. Accessed January 8, 2010.
27. Elstein AS, Chapman GB, Knight SJ. Patients' values and clinical substituted judgments: the case of localized prostate cancer. Health Psychol. 2005;24(4)(suppl):S85-S92.
28. Sawyer SM, Fardy HJ. Bridging the gap between doctors' and patients' expectations of asthma management. J Asthma. 2003;40(2):131-138.
29. Spoorenberg A, van Tubergen A, Landewe R, et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford). 2005;44(6):789-795.
30. Longacre AV, Imaeda A, Garcia-Tsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology. 2008;47(1):169-176.
31. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605. doi:10.1136/bmj.b605.
32. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8)(suppl 2):S13-S24.
33. Jones N III, Jones S, Miller N. The Medicare Health Outcomes Survey program: overview, context, and near-term prospects. Health Qual Life Outcomes. 2004;2:33. (Pubitemid 39111998)